← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 1, 2012Last known activity
Oct 28, 2021
Acquired by Pfizer on Aug 23, 2021
Timeline
2000s
- Jun 1, 2004
Trillium Therapeutics Inc.— Founded
2010s
- Feb 4, 2013
Stem Cell Therapeutics Corp.— Acquired
- Jan 26, 2016
Fluorinov Pharma— Acquired
2020s
- Aug 23, 2021
Pfizer— Acquired By
Drugs by trial phase (13 distinct, 10 trials)
Phase 2 (2 own, 3 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Indications
Subsidiaries (2 direct, 2 total across the full acquisition tree)
Recent trials (10)
- NCT05139225CollaboratorPhase 1Oct 28, 2021
- NCT04996004Lead sponsorPhase 1/Phase 2Jun 25, 2021
- NCT03530683Lead sponsorPhase 1May 1, 2018
- NCT03530683Study directorPhase 1May 1, 2018
- NCT02890368Lead sponsorPhase 1Sep 1, 2016
- NCT02890368Study chairPhase 1Sep 1, 2016
- NCT02663518Study chairPhase 1Jan 1, 2016
- NCT02663518Lead sponsorPhase 1Jan 1, 2016
- NCT01559961Lead sponsorPhase 1Mar 1, 2012
- NCT01559961Study directorPhase 1Mar 1, 2012
Details
- Founded
- Toronto, ON, CA Jun 1, 2004
- Last known activity
- Oct 28, 2021